Vaccines

Date: Oct-2019 | Id: MACRC-0111 | Geographical Scope: United States

The United States influenza vaccines market size is anticipated to observe tremendous growth projections during 2019 - 2025.

Date: Jun-2018 | Id: MACRC-0076 | Geographical Scope: United States

United States pediatric vaccines market is expected to grow over US$ 15 Billion by 2025, driven by increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for ...

Date: Nov-2017 | Id: MACRC-0063 | Geographical Scope: United States

United States Pediatric Vaccine market is likely to reach nearly US$ 10 Billion by 2024.

Date: Apr-2016 | Id: MACRC-0059 | Geographical Scope: United States

United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024. Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to...

Date: Apr-2016 | Id: MACRC-0043 | Geographical Scope: Global

Zika virus is an emerging viral disease that is transmitted through the bite of an infected mosquito, primarily Aedes aegypti, the same vector that transmits chikungunya, dengue and yellow fever. Zika has a similar epidemiology, clinical present...

Date: Apr-2016 | Id: MACRC-0042 | Geographical Scope: Europe

Influenza Vaccine Market is expected to reach more than US$ 1 Billion across the 5 major markets (5MM) of the France, Germany, Italy, Spain and United Kingdom by the year end of 2022.

Date: Apr-2021 | Id: MACRC-0041 | Geographical Scope: United States

United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022.

Date: Apr-2016 | Id: MACRC-0040 | Geographical Scope: Global

Seasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion across the seven major markets (7MM) of the United States, France, Germany, Italy, Spain, United Kingdom and Japan by the year end of 2022.